Systemic inflammation, as measured by the neutrophil/lymphocyte ratio, may have differential prognostic impact before and during treatment with fluorouracil, irinotecan and bevacizumab in metastatic colorectal cancer patients

导出原文传递

翻译打印收藏纠错

作者： Formica, Vincenzo ^[1] ; Luccchetti, Jessica ^[2] ; Cunningham, David ^[3] ; Smyth, Elizabeth C. ^[4] ; Ferroni, Patrizia ; Nardecchia, Antonella ; Tesauro, Manfredi ; Cereda, Vittore ; Guadagni, Fiorella ; Roselli, Mario

作者单位： IRCCS San Raffaele Pisana, Dept Adv Biotechnol & Bioimaging, Rome, Italy ^[1] Tor Vergata Univ Hosp Rome, Dept Internal Med, Rome, Italy ^[2] Royal Marsden Hosp, Gastrointestinal Res Units, Dept Med, Sutton, Surrey, England ^[3] Tor Vergata Univ Hosp, Med Oncol Unit, Dept Internal Med, I-00133 Rome, Italy ^[4]

关键词 Neutrophil/lymphocyte ratio Metastatic colorectal cancer Bevacizumab Systemic inflammation

发布时间 2015-10-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交